The Food and Drug Administration (FDA) has approved Watson's Rosuvastatin Calcium Tablets, the first generic version of AstraZeneca's Crestor.
Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin.
All products are currently on backorder, which is expected to resolve by July 2016.
Bayer announced that the Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance angiography (MRA) to evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates.
Experts from the FDA Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee will meet in May.